Randox have identified a cardiac marker which has a prognostic value.
Elevated H-FABP is a significant predictor of death or MI within 1 year
H-FABP provides additional prognostic information independent of Troponin T, ECG and clinical examination
Increased H-FABP concentrations confers increased risk
"Patients with H-FABP concentrations >6.48 µg/L had significantly increased risk of adverse events"
"Among Troponin negative patients, the cut-off of 6.48 µg/L identified patients at very high risk of adverse outcomes independent of patient age and serum Creatinine"
|
Replied on Monday, November 15, 2010 7:33 AM
|
|